NASDAQ · LNSR
LENSAR, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for LNSR: Nov 5, 2026
LENSAR, Inc. Common Stock is estimated to report earnings on 11/05/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. The reported EPS for the same quarter last year was $-0.31.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
The Motley Fool · MarketBeat · RTTNews · Fintel- The Motley Fool · Aug 20, 10:13 AM EDTLENSAR (LNSR) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- MarketBeat · Aug 13, 1:04 PM EDTLENSAR Q2 Earnings Call HighlightsLENSAR (NASDAQ:LNSR) reported second-quarter 2026 revenue growth of 18% as the company continued to rebuild commercial momentum following the termination of its proposed merger with Alcon near the end of the first quarter. Chief Executive Officer Nick Curtis said the company ret
- RTTNews · Aug 13, 10:07 AM EDTLENSAR Soars Over 25% As Q2 Revenue Jumps 18%; Swings To Profit(RTTNews) – Shares of LENSAR, Inc. (LNSR), a commercial-stage medical device company, are surging over 25% after the company reported financial results for the second quarter of 2026, reflecting a return to profit backed by 18% revenue growth and 20% growth in recurring revenue.
- The Motley Fool · Jun 1, 1:10 PM EDTLensar (LNSR) Q1 2026 Earnings Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- The Motley Fool · Jun 1, 1:10 PM EDTLensar (LNSR) Q4 2025 Earnings Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- MarketBeat · May 8, 2:20 PM EDTLENSAR Q1 Earnings Call HighlightsLENSAR (NASDAQ:LNSR) executives told investors on Thursday that the company is moving past a “transaction-related holding pattern” after the termination of its planned merger, and is now refocusing on rebuilding commercial momentum around its ALLY femtosecond laser cataract platf
- RTTNews · Mar 20, 10:13 AM EDTWeekly Buzz: GSK's Lynavoy Gets FDA Nod; Reproxalap Rejected Again; LNSR Ends Merger Deal(RTTNews) – This week's biotech landscape witnessed key FDA approvals, rejections, NDA resubmissions, merger terminations, trial discontinuations, and clinical trial data readouts across therapeutic areas such as Turner Syndrome, Late-Line Colorectal Cancer, Obesity, and Type 1 D
- Fintel · Mar 18, 8:09 AM EDTBTIG Upgrades LENSAR (LNSR)Fintel reports that on March 18, 2026, BTIG upgraded their outlook for LENSAR (NasdaqCM:LNSR) from Neutral to Buy. Analyst Price Forecast Suggests 122.06% Upside
- RTTNews · Mar 17, 4:58 AM EDTLENSAR Terminates Merger Agreement With Alcon Research; Stock Down(RTTNews) – LENSAR, Inc. (LNSR), a commercial-stage medical device firm focused on developing robotic laser solutions for the treatment of cataracts, announced that it reached an agreement to terminate the merger agreement with Alcon Research, LLC, entered into in March 2025.
- The Motley Fool · Aug 7, 10:38 AM EDTLensar (LNSR) Q2 Revenue Rises 10%Revenue (GAAP) increased 10% year over year in Q2 2025. Revenue (GAAP) missed analyst expectations by $3.165 million in Q2 2025.
- Quiver Quantitative · Jul 1, 4:13 PM EDTLENSAR, Inc. Grants 660 Restricted Stock Units to New Non-Executive Employees as Inducement for EmploymentLENSAR grants 660 RSUs to three new employees as part of their employment inducement plan effective July 1, 2025.
- Quiver Quantitative · Jun 2, 4:13 PM EDTLENSAR, Inc. Grants 3,090 Restricted Stock Units to New Employees as Inducement for EmploymentLENSAR grants 3,090 restricted stock units to 10 new employees as part of their employment incentives.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for LENSAR, Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.